Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff upgraded Capricor Therapeutics (NASDAQ: CAPR) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
